Vikas Prasad

6.2k total citations · 1 hit paper
172 papers, 3.6k citations indexed

About

Vikas Prasad is a scholar working on Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vikas Prasad has authored 172 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 82 papers in Epidemiology and 66 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vikas Prasad's work include Neuroendocrine Tumor Research Advances (77 papers), Lung Cancer Research Studies (56 papers) and Neuroblastoma Research and Treatments (55 papers). Vikas Prasad is often cited by papers focused on Neuroendocrine Tumor Research Advances (77 papers), Lung Cancer Research Studies (56 papers) and Neuroblastoma Research and Treatments (55 papers). Vikas Prasad collaborates with scholars based in Germany, United States and Switzerland. Vikas Prasad's co-authors include Richard P. Baum, Merten Hommann, Winfried Brenner, Daniel Kaemmerer, Timm Denecke, Christiane Schuchardt, Marcus R. Makowski, Dirk Müller, Harshad Kulkarni and Valentina Ambrosini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Vikas Prasad

161 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

2023 95 citations Johannes Hofland, Massimo Falconi et al. Journal of Neuroendocrinology profile →

Peers

Countries citing papers authored by Vikas Prasad

Since Specialization

Citations

This map shows the geographic impact of Vikas Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Prasad more than expected).

Fields of papers citing papers by Vikas Prasad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Prasad. The network helps show where Vikas Prasad may publish in the future.

Co-authorship network of co-authors of Vikas Prasad

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Prasad. A scholar is included among the top collaborators of Vikas Prasad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Prasad. Vikas Prasad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism 2025 ·EJNMMI Research ·Peter Kühnen, (unknown), K Rothe, (unknown), Kathrin Hauptmann, Marti Boss, Nicola Beindorff, Erwin Lankes, Steven W. Warmann, (unknown), (unknown), (unknown), Catharina Lange, Christian Furth, Martin Gotthardt, Winfried Brenner, Oliver Blankenstein, Vikas Prasad	0
2	NETest ® 2.0—A decade of innovation in neuroendocrine tumor diagnostics 2025 ·Journal of Neuroendocrinology ·Mark Kidd, Ignat Drozdov, Alin Chirindel, Guillaume Nicolas, David K. Imagawa, Ajay Gulati, Takahiro Tsuchikawa, Vikas Prasad, (unknown), Jonathan Strosberg	2
3	Frontiers in radiopharmaceuticals for neuroendocrine tumors 2025 ·Journal of Neuroendocrinology ·Ameya Puranik, (unknown), Vikas Prasad	0
4	Sustainability Through Connectivity: IoT Influence on Agriculture 2025 ·Journal of Computer Science ·(unknown), (unknown), Dharmendra Sharma, Vikas Prasad, (unknown), (unknown), Vinod Patidar, Sudheer Kumar	0
5	Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies 2024 ·Current Problems in Cancer ·(unknown), Burçak Yılmaz, Catherine Meyer, (unknown), (unknown), Abhinav K. Jha, Vikas Prasad, Erik Mittra	1
6	Use of approved Lu ‐177 radiopharmaceuticals in patients with end‐stage renal disease: A review of the literature and proposed treatment algorithm 2024 ·Journal of Neuroendocrinology ·Nikolaos A. Trikalinos, Hyun Kim, Anitha Vijayan, (unknown), Vikas Prasad	3
7	Patlak Slope versus Standardized Uptake Value Image Quality in an Oncologic PET/CT Population: A Prospective Cross-Sectional Study 2024 ·Diagnostics ·Semra İnce, Richard Laforest, Malak Itani, Vikas Prasad, Saeed Ashrafinia, Anne M. Smith, Richard L. Wahl, Tyler J. Fraum	1
8	Current and Future Perspectives of PDL1 PET and SPECT Imaging 2024 ·Seminars in Nuclear Medicine ·(unknown), Ameya Puranik, Baljinder Singh, Vikas Prasad	3
9	A Drug-Target Interaction Prediction Based on Supervised Probabilistic Classification 2023 ·Journal of Computer Science ·Manmohan Singh, (unknown), G. Swapna, (unknown), Vikas Prasad, Vinod Patidar, Dharmendra Sharma, (unknown)	6
10	India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate 2023 ·Indian Journal of Nuclear Medicine ·Baljinder Singh, (unknown), Vikas Prasad, (unknown), (unknown)	4
11	European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes breakdown → 2023 ·Journal of Neuroendocrinology ·Johannes Hofland, Massimo Falconi, Emanuel Christ, Justo P. Castaño, Antongiulio Faggiano, Ángela Lamarca, Aurel Perren, Simona Petrucci, Vikas Prasad, Philippe Ruszniewski, Christina Thirlwell, Marie‐Pierre Vullierme, Staffan Welin, Detlef K. Bartsch	95
12	S2k‐Leitlinie – Merkelzellkarzinom – Update 2022 2023 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Jürgen C. Becker, Ambros J. Beer, (unknown), Thomas Eigentler, Michael J. Flaig, Thilo Gambichler, Stephan Grabbe, Ulrike Höller, Bernhard Klumpp, Stephan Lang, Claudia Pföhler, Christian Posch, Vikas Prasad, Peter Schlattmann, Sylke Schneider‐Burrus, (unknown), Patrick Terheyden, (unknown), Dirk Vordermark, Selma Ugurel	2
13	European Neuroendocrine Tumor Society ( ENETS ) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease 2022 ·Journal of Neuroendocrinology ·Simona Grozinsky‐Glasberg, Joseph Davar, Johannes Hofland, Rebecca Dobson, Vikas Prasad, Andreas Pascher, Timm Denecke, Margot Tesselaar, Francesco Panzuto, Anders Albåge, Heidi M. Connolly, Jean‐François Obadia, Rachel P. Riechelmann, Christos Toumpanakis	76
14	ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Clarisse Dromain, Marie‐Pierre Vullierme, Rodney J. Hicks, Vikas Prasad, (unknown), Wouter W. de Herder, Marianne Pavel, Antongiulio Faggiano, Beata Kos‐Kudła, Kjell Öberg, Guenter J. Krejs, Enrique Grande, Bruno Niederle, Anders Sundin	13
15	ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Éric Raymond, Lisa Bodei, Halfdan Sørbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James C. Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad	13
16	Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATOC 2021 ·Indian Journal of Nuclear Medicine ·Vikas Prasad, (unknown), Wencke Lehnert, Winfried Brenner, (unknown), Marcus Bronzel, Andreas Kluge	1
17	Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer 2021 ·Cancers ·Ameya Puranik, Clarisse Dromain, Neil Fleshner, Mike Sathekge, Marianne Pavel, Nina Eberhardt, Friedemann Zengerling, Ralf Marienfeld, Michael Grunert, Vikas Prasad	19
18	Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features 2017 ·Neuroendocrinology ·(unknown), Marianne Pavel, Ingo G. Steffen, Alexander Baur, (unknown), Christian Fischer, Katharina Detjen, Vikas Prasad, Andreas Pascher, Dominik Geisel, Timm Denecke	29
19	An Effective Healthcare Management Frame work in Cloud Computing Environment 2016 ·Vikas Prasad, Ram Prakash, Harish Kumar, (unknown), Clas‐Håkan Nygård, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. 2012 ·PubMed ·Daniel Kaemmerer, Luisa Peter, Amelie Lupp, Stefan Schulz, Jörg Sänger, Richard P. Baum, Vikas Prasad, Merten Hommann	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact